Optimising inter-patient image registration for image-based data mining in breast radiotherapy.

Breast radiotherapy Image registration Image-based data mining Spatial normalisation

Journal

Physics and imaging in radiation oncology
ISSN: 2405-6316
Titre abrégé: Phys Imaging Radiat Oncol
Pays: Netherlands
ID NLM: 101704276

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 20 07 2024
revised: 19 08 2024
accepted: 20 08 2024
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: epublish

Résumé

Image-based data mining (IBDM) requires spatial normalisation to reference anatomy, which is challenging in breast radiotherapy due to variations in the treatment position, breast shape and volume. We aim to optimise spatial normalisation for breast IBDM. Data from 996 patients treated with radiotherapy for early-stage breast cancer, recruited in the REQUITE study, were included. Patients were treated supine (n = 811), with either bilateral or ipsilateral arm(s) raised (551/260, respectively) or in prone position (n = 185). Four deformable image registration (DIR) configurations for extrathoracic spatial normalisation were tested. We selected the best-performing DIR configuration and further investigated two pathways: DIR using B-spline and normalised mutual information (NMI) performed the best across all evaluation metrics. Supine-supine registrations yielded highest accuracy (0.98 ± 0.01, 0.91 ± 0.04, 0.23 ± 0.19 cm, 1.17 ± 1.18 cm, 0.51 ± 0.26 cm for NCC, DSC, MDA, 95 %HD, and ILRU), followed by prone-prone and supine-prone registrations. Arm positioning had no significant impact on registration performance. For the best DIR strategy, uncertainty of 0.44 and 0.81 cm in the breast and shoulder regions was found. B-spline algorithm using NMI and registered supine and prone cohorts independently provides the most optimal spatial normalisation strategy for breast IBDM.

Sections du résumé

Background and purpose UNASSIGNED
Image-based data mining (IBDM) requires spatial normalisation to reference anatomy, which is challenging in breast radiotherapy due to variations in the treatment position, breast shape and volume. We aim to optimise spatial normalisation for breast IBDM.
Materials and methods UNASSIGNED
Data from 996 patients treated with radiotherapy for early-stage breast cancer, recruited in the REQUITE study, were included. Patients were treated supine (n = 811), with either bilateral or ipsilateral arm(s) raised (551/260, respectively) or in prone position (n = 185). Four deformable image registration (DIR) configurations for extrathoracic spatial normalisation were tested. We selected the best-performing DIR configuration and further investigated two pathways:
Results UNASSIGNED
DIR using B-spline and normalised mutual information (NMI) performed the best across all evaluation metrics. Supine-supine registrations yielded highest accuracy (0.98 ± 0.01, 0.91 ± 0.04, 0.23 ± 0.19 cm, 1.17 ± 1.18 cm, 0.51 ± 0.26 cm for NCC, DSC, MDA, 95 %HD, and ILRU), followed by prone-prone and supine-prone registrations. Arm positioning had no significant impact on registration performance. For the best DIR strategy, uncertainty of 0.44 and 0.81 cm in the breast and shoulder regions was found.
Conclusions UNASSIGNED
B-spline algorithm using NMI and registered supine and prone cohorts independently provides the most optimal spatial normalisation strategy for breast IBDM.

Identifiants

pubmed: 39310222
doi: 10.1016/j.phro.2024.100635
pii: S2405-6316(24)00105-2
pmc: PMC11413750
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100635

Informations de copyright

© 2024 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tanwiwat Jaikuna (T)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Fiona Wilson (F)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

David Azria (D)

University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute ICM, Université Montpellier, INSERM 1194 IRCM, Montpellier, France.

Jenny Chang-Claude (J)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Germany.

Maria Carmen De Santis (MC)

Radiation Oncology, Fondazione IRCCS Isituto Nazionale dei Tumori, Milan, Italy.

Sara Gutiérrez-Enríquez (S)

Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, Barcelona, Spain.

Marcel van Herk (M)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

Peter Hoskin (P)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

Lea Kotzki (L)

University Federation of Radiation Oncology of Mediterranean Occitanie, Gard Cancer Institute ICG, CHU Caremeau, Nimes, France.

Maarten Lambrecht (M)

KU Leuven, Department of Radiation Oncology, Leuven, Belgium.

Zoe Lingard (Z)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

Petra Seibold (P)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Alejandro Seoane (A)

Medical Physics Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Elena Sperk (E)

Department of Radiation Oncology, Mannheim Cancer Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

R Paul Symonds (R)

Leicester Cancer Research Centre, University of Leicester, United Kingdom.

Christopher J Talbot (CJ)

Leicester Cancer Research Centre, University of Leicester, United Kingdom.

Tiziana Rancati (T)

Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Tim Rattay (T)

Leicester Cancer Research Centre, University of Leicester, United Kingdom.

Victoria Reyes (V)

Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Barry S Rosenstein (BS)

Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, USA.

Dirk de Ruysscher (D)

Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands.

Ana Vega (A)

Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain.
Instituto de Investigación Sanitaria de, Santiago de Compostela, Spain.
Biomedical Network on Rare Diseases (CIBERER), Spain.

Liv Veldeman (L)

Ghent University Hospital, Department of Radiation Oncology, Ghent, Belgium.

Adam Webb (A)

Department of Genetics and Genome Biology, University of Leicester, United Kingdom.

Catharine Ml West (CM)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

Marianne C Aznar (MC)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

Eliana Vasquez Osorio (E)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom.

Classifications MeSH